Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated from v3.6.2 to v3.6.3, indicating a minor version update to the page. This change does not modify visible content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-04T04:12:23.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's version. No changes to the study details are reflected in this update.
    Difference
    0.1%
    Check dated 2026-06-27T01:50:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    No longer looking for participants is now shown on the page, indicating the study has closed enrollment. This update communicates that eligibility and enrollment are no longer active for this trial.
    Difference
    0.4%
    Check dated 2026-06-12T16:46:18.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.5.5) replacing the previous v3.5.4, indicating a minor version update to the page's version.
    Difference
    0.1%
    Check dated 2026-06-05T12:37:12.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.4 tag, representing a small software update to the ClinicalTrials.gov page. This change does not modify the study content or documents.
    Difference
    0.1%
    Check dated 2026-05-15T05:39:17.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page’s release/version indicator was incremented from “v3.5.2” to “v3.5.3,” reflecting a minor site revision rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.